- Home
- ROIV vs MIDD Comparison
ROIV vs MIDD Comparison
Compare ROIV & MIDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | MIDD |
|---|---|---|
| Founded | 2014 | 1888 |
| Country | United Kingdom | United States |
| Employees | 721 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.7B | 6.1B |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ROIV | MIDD |
|---|---|---|
| Price | $35.99 | $105.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 8 |
| Target Price | $28.94 | ★ $180.13 |
| AVG Volume (30 Days) | ★ 8.7M | 513.4K |
| Earning Date | 05-28-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | $8,260,000.00 | ★ $3,201,202,000.00 |
| Revenue This Year | N/A | $5.87 |
| Revenue Next Year | $744.61 | $3.22 |
| P/E Ratio | ★ N/A | $1,066.80 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.11 | $104.24 |
| 52 Week High | $42.50 | $180.13 |
Technical Indicators
Market Signals| Indicator | ROIV | MIDD |
|---|---|---|
| Relative Strength Index (RSI) | 43.25 | 33.37 |
| Support Level | $33.15 | $104.24 |
| Resistance Level | $36.35 | $113.85 |
| Average True Range (ATR) | 1.33 | 2.75 |
| MACD | -0.51 | 0.29 |
| Stochastic Oscillator | 11.68 | 17.27 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About MIDD Middleby Corporation (The)
The Middleby Corp is engaged in the foodservice industry. The company develops and manufactures a broad line of solutions used in commercial foodservice and food processing. The group showcases its solutions in the Middleby Innovation Kitchens for commercial foodservice and industrial baking and protein Innovation Centers for food processing solutions.